Obsidian Therapeutics Patents – Insights & Stats (Updated 2023)

Obsidian Therapeutics has a total of 127 patents globally, out of which 7 have been granted. Of these 127 patents, more than 81% patents are active. The USA is where Obsidian Therapeutics has filed the maximum number of patents, followed by Europe (EPO) and Hong Kong. Parallelly, the US seems to be the main focused R&D center of Obsidian Therapeutics and is also the origin country of the firm.

Obsidian Therapeutics was founded in the year 2015 by Michael Gilman, Steve Shamah and Tariq Kassum. The company is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.

Do read about some of the most popular patents of Obsidian Therapeutics which have been covered by us in this article and also you can find Obsidian Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Obsidian Therapeutics patent portfolio.

How many patents does Obsidian Therapeutics have?

Obsidian Therapeutics has a total of 127 patents globally. These patents belong to 22 unique patent families. Out of 127 patents, 104 patents are active.

How Many Patents did Obsidian Therapeutics File Every Year?

Obsidian Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantObsidian Therapeutics Applications FiledObsidian Therapeutics Patents Granted
2022242
2021211
202037
201916
201818
20173
2016
2015

How many Obsidian Therapeutics patents are Alive/Dead?

Worldwide Patents

Obsidian Therapeutics Patent Portfolio

How Many Patents did Obsidian Therapeutics File in Different Countries?

Obsidian Therapeutics Worldwide Patent Filing

Where are Research Centres of Obsidian Therapeutics Patents Located?

The R&D Centres of Obsidian Therapeutics is in the USA.

10 Best Obsidian Therapeutics Patents

CA3055202A1 is the most popular patent in the Obsidian Therapeutics portfolio. It has received 6 citations so far.

Below is the list of 10 most cited patents of Obsidian Therapeutics:

Publication NumberCitation Count
CA3055202A16
WO2020252404A16
US20210386788A15
WO2022060806A14
WO2021050789A14
WO2020185628A13
WO2017180587A33
US11446398B22
US11058725B22
US20220403001A12

What are Obsidian Therapeutics’ key innovation segments?

What Technologies are Covered by Obsidian Therapeutics?

The chart below distributes patents filed by Obsidian Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Obsidian Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Obsidian Therapeutics’ search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Obsidian Therapeutics?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.